Trials / Completed
CompletedNCT04468633
The Baerveldt Versus ClearPath Comparison Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized prospective study of post-operative surgical outcomes and complication rates in patients with a Baerveldt 350 implant vs the Ahmed ClearPath implant. Each subject will be randomized to the Baerveldt group or ClearPath group at the time of consent for the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Baerveldt 350 implant | The Baerveldt implant is an FDA-approved silicone, non-valved implant. |
| DEVICE | Ahmed ClearPath 350 implant | The Ahmed ClearPath is a non-valved glaucoma drainage device. |
Timeline
- Start date
- 2020-12-17
- Primary completion
- 2023-06-29
- Completion
- 2023-06-29
- First posted
- 2020-07-13
- Last updated
- 2024-09-05
- Results posted
- 2024-09-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04468633. Inclusion in this directory is not an endorsement.